These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Exosomes from Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells (hiPSC-MSCs) Protect Liver against Hepatic Ischemia/ Reperfusion Injury via Activating Sphingosine Kinase and Sphingosine-1-Phosphate Signaling Pathway. Du Y; Li D; Han C; Wu H; Xu L; Zhang M; Zhang J; Chen X Cell Physiol Biochem; 2017; 43(2):611-625. PubMed ID: 28934733 [TBL] [Abstract][Full Text] [Related]
26. Liver biopsy derived induced pluripotent stem cells provide unlimited supply for the generation of hepatocyte-like cells. Calabrese D; Roma G; Bergling S; Carbone W; Mele V; Nuciforo S; Fofana I; Campana B; Szkolnicka D; Hay DC; Tchorz J; Bouwmeester T; Wieland S; Heim MH PLoS One; 2019; 14(8):e0221762. PubMed ID: 31465481 [TBL] [Abstract][Full Text] [Related]
27. Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis. Zou A; Magee N; Deng F; Lehn S; Zhong C; Zhang Y J Biol Chem; 2018 Jun; 293(22):8656-8671. PubMed ID: 29666185 [TBL] [Abstract][Full Text] [Related]
28. iPSC-derived hepatocytes generated from NASH donors provide a valuable platform for disease modeling and drug discovery. Gurevich I; Burton SA; Munn C; Ohshima M; Goedland ME; Czysz K; Rajesh D Biol Open; 2020 Dec; 9(12):. PubMed ID: 33268331 [TBL] [Abstract][Full Text] [Related]
29. Human mesenchymal stem cells towards non-alcoholic steatohepatitis in an immunodeficient mouse model. Winkler S; Borkham-Kamphorst E; Stock P; Brückner S; Dollinger M; Weiskirchen R; Christ B Exp Cell Res; 2014 Aug; 326(2):230-9. PubMed ID: 24786317 [TBL] [Abstract][Full Text] [Related]
30. hiPSC hepatocyte model demonstrates the role of unfolded protein response and inflammatory networks in α Segeritz CP; Rashid ST; de Brito MC; Serra MP; Ordonez A; Morell CM; Kaserman JE; Madrigal P; Hannan NRF; Gatto L; Tan L; Wilson AA; Lilley K; Marciniak SJ; Gooptu B; Lomas DA; Vallier L J Hepatol; 2018 Oct; 69(4):851-860. PubMed ID: 29879455 [TBL] [Abstract][Full Text] [Related]
31. The Effect of Glyceraldehyde-Derived Advanced Glycation End Products on β-Tubulin-Inhibited Neurite Outgrowth in SH-SY5Y Human Neuroblastoma Cells. Nasu R; Furukawa A; Suzuki K; Takeuchi M; Koriyama Y Nutrients; 2020 Sep; 12(10):. PubMed ID: 32992566 [TBL] [Abstract][Full Text] [Related]
32. A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host. Sa-Ngiamsuntorn K; Wongkajornsilp A; Phanthong P; Borwornpinyo S; Kitiyanant N; Chantratita W; Hongeng S Virol J; 2016 Apr; 13():59. PubMed ID: 27044429 [TBL] [Abstract][Full Text] [Related]
33. Systematic transcriptome-based comparison of cellular adaptive stress response activation networks in hepatic stem cell-derived progeny and primary human hepatocytes. Ter Braak B; Niemeijer M; Boon R; Parmentier C; Baze A; Richert L; Huppelschoten S; Wink S; Verfaillie C; van de Water B Toxicol In Vitro; 2021 Jun; 73():105107. PubMed ID: 33545341 [TBL] [Abstract][Full Text] [Related]
34. The Association between Accumulation of Toxic Advanced Glycation End-Products and Cytotoxic Effect in MC3T3-E1 Cells. Sakasai-Sakai A; Takata T; Takeuchi M Nutrients; 2022 Feb; 14(5):. PubMed ID: 35267965 [TBL] [Abstract][Full Text] [Related]
35. A liver-specific long noncoding RNA with a role in cell viability is elevated in human nonalcoholic steatohepatitis. Atanasovska B; Rensen SS; van der Sijde MR; Marsman G; Kumar V; Jonkers I; Withoff S; Shiri-Sverdlov R; Greve JWM; Faber KN; Moshage H; Wijmenga C; van de Sluis B; Hofker MH; Fu J Hepatology; 2017 Sep; 66(3):794-808. PubMed ID: 28073183 [TBL] [Abstract][Full Text] [Related]
36. Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions. Xia Y; Carpentier A; Cheng X; Block PD; Zhao Y; Zhang Z; Protzer U; Liang TJ J Hepatol; 2017 Mar; 66(3):494-503. PubMed ID: 27746336 [TBL] [Abstract][Full Text] [Related]
37. Potential of an Interorgan Network Mediated by Toxic Advanced Glycation End-Products in a Rat Model. Inoue S; Takata T; Nakazawa Y; Nakamura Y; Guo X; Yamada S; Ishigaki Y; Takeuchi M; Miyazawa K Nutrients; 2020 Dec; 13(1):. PubMed ID: 33383715 [TBL] [Abstract][Full Text] [Related]
38. Functional Characterization of Organoids Derived From Irreversibly Damaged Liver of Patients With NASH. McCarron S; Bathon B; Conlon DM; Abbey D; Rader DJ; Gawronski K; Brown CD; Olthoff KM; Shaked A; Raabe TD Hepatology; 2021 Oct; 74(4):1825-1844. PubMed ID: 33901295 [TBL] [Abstract][Full Text] [Related]
39. Toxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALD. Takeuchi M; Takino JI; Sakasai-Sakai A; Takata T; Tsutsumi M Nutrients; 2017 Jun; 9(6):. PubMed ID: 28632197 [TBL] [Abstract][Full Text] [Related]
40. Effects of Toxic AGEs (TAGE) on Human Health. Takeuchi M; Sakasai-Sakai A; Takata T; Takino JI; Koriyama Y Cells; 2022 Jul; 11(14):. PubMed ID: 35883620 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]